GLP-3RT (RETA)

GLP-3RT (RETA) in Laboratory Research

GLP-3RT (RETA) is a synthetic peptide designed to activate three receptors simultaneously — GLP-1, GIP and glucagon. It represents the current frontier of multi-receptor agonist design and is studied as a probe for how combined receptor engagement differs from single- or dual-target compounds.

In controlled laboratory settings, research groups use GLP-3RT (RETA) as a reference standard when investigating the pharmacology of triple-agonist molecules against established single- and dual-agonist comparators.

Research Applications & Study Focus

Typical applications include comparative receptor-affinity panels, downstream signalling and cAMP assays, and metabolic-pathway characterisation in cell-based systems. It is frequently studied alongside GLP-2TRZ (TIRZ) and other incretin analogs to separate the contribution of each receptor arm.

It is offered in 15 mg, 30 mg and 60 mg vials, and its consistent lot specification lets laboratories reproduce receptor-pharmacology conditions across repeated experiments.

Purity, Handling & Verification

Each batch is supplied as a sealed, lyophilized vial and is independently analysed by a third-party laboratory using HPLC and mass spectrometry; the full certificate of analysis is published against its lot number, so results can be verified before use. Store the lyophilized material cool, dry and out of direct light, and reconstitute with bacteriostatic water under standard aseptic laboratory practice.

This material is offered strictly for in vitro laboratory research use only. It is not for human or veterinary consumption, and not for diagnostic or therapeutic use.